Frankfurt
07.09.26 | 15:25
0,266 Euro
-4,66 % -0,013
1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,240 | 0,342 | 20:13 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 05.08. | Senzime Awarded Exclusive 5-Year National Supply Contract with U.S. Veterans Affairs Through Its Partner TrillaMed | 389 | ACCESS Newswire | UPPSALA, SE / ACCESS Newswire / August 5, 2026 / Senzime AB (publ) (STO:SEZI)(OTCQX:SNZZF), a leader in precision-based perioperative monitoring solutions, today announced that the U.S. Department of... ► Artikel lesen | |
| 16.07. | Senzime AB (publ) reports Q2 results | 1 | Seeking Alpha | ||
| SENZIME Aktie jetzt für 0€ handeln | |||||
| 16.07. | Senzime: Interim Report Q2 2026: Strong Sensor Sales and Improved Margins, Despite Continued U.S. Monitor Market Headwinds | 533 | ACCESS Newswire | UPPSALA, SE / ACCESS Newswire / July 16, 2026 / Senzime AB's (publ) (STO:SEZI)(OTCQX:SNZZF) interim report for April - June (Q2) 2026 is now available on the company's website www.senzime.com.Financial... ► Artikel lesen | |
| 15.07. | Senzime and Philips Medical Systems Enter Development and Commercialization Partnership | 482 | ACCESS Newswire | UPPSALA, SE / ACCESS Newswire / July 15, 2026 / Senzime (STO:SEZI)(OTCQX:SNZZF) - Senzime AB announced today that it has entered into a long-term agreement with Philips Electronics Nederland, B.V. through... ► Artikel lesen | |
| 13.07. | Invitation to Presentations of Senzime's Second Quarter 2026 Report | 336 | ACCESS Newswire | UPPSALA, SE / ACCESS Newswire / July 13, 2026 / Senzime (STO:SEZI)(OTCQX:SNZZF) invites investors, analysts, and media to presentations of the second quarter report for 2026 on July 16. The report will... ► Artikel lesen | |
| 29.06. | Senzime's TetraGraph System Receives ANVISA Regulatory Approval in Brazil | 360 | ACCESS Newswire | UPPSALA, SE / ACCESS Newswire / June 29, 2026 / Senzime (STO:SEZI)(OTCQX:SNZZF) announced today that the TetraGraph system has received approval from the Brazilian Health Regulatory Agency (ANVISA)... ► Artikel lesen | |
| 05.06. | Senzime to Showcase Expanded TetraGraph Capabilities with Launch of TetraAnalytics at Euroanaesthesia 2026 | 339 | ACCESS Newswire | UPPSALA, SE / ACCESS Newswire / June 5, 2026 / Senzime AB (STO:SEZI)(OTCQX:SNZZF), a global leader in precision-based patient monitoring, today announced the launch of TetraAnalytics, a new data analytics... ► Artikel lesen | |
| 03.06. | Senzime Strengthens Position in Pediatric Anesthesia by Securing Another Hospital Contract and Highlighting Positive Outcome Data | 371 | ACCESS Newswire | UPPSALA, SE / ACCESS Newswire / June 3, 2026 / Senzime AB (STO:SEZI)(OTCQX:SNZZF) announced today advancements within pediatric anesthesia, securing another top ranked pediatric hospital contract. The... ► Artikel lesen | |
| 01.06. | Senzime Advances Sustainable Anesthesia Monitoring with Launch of New EMG Sensor | 319 | ACCESS Newswire | UPPSALA, SE / ACCESS Newswire / June 1, 2026 / Senzime AB (STO:SEZI)(OTCQX:SNZZF) today announced the launch of its latest TetraSens EMG sensor for use with the TetraGraph Train-of-Four monitoring system.... ► Artikel lesen | |
| 27.05. | From Science to Practice: Senzime Obtains FDA 510(k) Clearance for Enhanced TetraGraph System | 571 | ACCESS Newswire | UPPSALA, SE / ACCESS Newswire / May 27, 2026 / Senzime (STO:SEZI)(OTCQX:SNZZF) - Senzime AB today announced that its TetraGraph neuromuscular monitoring system has received an additional FDA Class II... ► Artikel lesen | |
| 19.05. | Bulletin From Annual General Meeting in Senzime AB | 405 | ACCESS Newswire | UPPSALA, SE / ACCESS Newswire / May 19, 2026 / Senzime (STO:SEZI) (OTCQX:SNZZF) - The annual general meeting in Senzime AB (publ), corp. reg. no 556565-5734 (the "Company") was held on 19 May 2026 at... ► Artikel lesen | |
| 29.04. | Senzime Strengthens U.S. Operations with New Leadership Appointments | 419 | ACCESS Newswire | UPPSALA, SE / ACCESS Newswire / April 29, 2026 / Senzime (STO:SEZI)(OTCQX:SNZZF) - Senzime AB today announced new appointments to its Global Executive Leadership Team, including the recruitment of a... ► Artikel lesen | |
| 24.04. | Senzime's TetraGraph System Contracted on Three Leading GPO Agreements in the US | 200 | ACCESS Newswire | UPPSALA, SE / ACCESS Newswire / April 24, 2026 / Senzime (STO:SEZI)(OTCQX:SNZZF) - Senzime AB today announced that the TetraGraph System has secured inclusion in agreements with Vizient, Premier, and... ► Artikel lesen | |
| 24.04. | Senzime Publishes Annual and Sustainability Report for 2025 | 189 | ACCESS Newswire | UPPSALA, SE / ACCESS Newswire / April 24, 2026 / Senzime (STO:SEZI)(OTCQX:SNZZF) - Senzime AB (publ) announces today that the company's annual and sustainability report for 2025 is published and available... ► Artikel lesen | |
| 22.04. | Senzime AB (publ) reports Q1 results | 2 | Seeking Alpha | ||
| 22.04. | Senzime: Margins Strengthened and Cash Flow Improved Despite a Temporary Dip in The Growth Trajectory. Full-Year Targets Remain on Track | 386 | ACCESS Newswire | UPPSALA, SE / ACCESS Newswire / April 22, 2026 / Senzime (STO:SEZI) (OTCQX:SNZZF) - Senzime AB's (publ) interim report for January - March 2026 is now available on the company's website www.senzime.com.Financial... ► Artikel lesen | |
| 20.04. | Senzime Wins Expanded Contract Within Leading Southeastern US Hospital System | 418 | ACCESS Newswire | UPPSALA, SE / ACCESS Newswire / April 20, 2026 / Senzime (STO:SEZI)(OTCQX:SNZZF) - Senzime AB today announced that it has expanded its agreements with a leading hospital system (IDN) with network in... ► Artikel lesen | |
| 17.04. | Notice of Annual General Meeting in Senzime AB | 468 | ACCESS Newswire | UPPSALA, SE / ACCESS Newswire / April 17, 2026 / Senzime (STO:SEZI)(OTCQX:SNZZF) - The shareholders in Senzime AB (publ) corp. reg. no 556565-5734 (the "Company") are hereby convened to an annual general... ► Artikel lesen | |
| 17.04. | Invitation to Presentations of Senzime's First Quarter 2026 Report | 334 | ACCESS Newswire | UPPSALA, SE / ACCESS Newswire / April 17, 2026 / Senzime (STO:SEZI)(OTCQX:SNZZF) - Senzime invites investors, analysts, and media to presentations of the first quarter report for 2026 on April 22. The... ► Artikel lesen | |
| 09.04. | Senzime Secures Strategic Hospital Orders Within Leading US Integrated Healthcare Delivery Network | 354 | ACCESS Newswire | UPPSALA, SE / ACCESS Newswire / April 9, 2026 / Senzime (STO:SEZI)(OTCQX:SNZZF) - Senzime AB today announced that it has secured strategic contracts to supply hospitals within one of the world's largest... ► Artikel lesen |
1 2 Weiter >>
39 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| CARL ZEISS MEDITEC | 32,140 | -1,87 % | EQS-DD: Carl Zeiss Meditec AG: Justus Felix Wehmer, Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
04.09.2026 / 17:25... ► Artikel lesen | |
| ECKERT & ZIEGLER | 12,740 | +0,47 % | Eckert & Ziegler: Berenbergs Kaufsignal überrascht | ||
| INTUITIVE SURGICAL | 319,00 | +1,05 % | ISRG's Ion Platform Is Quietly Becoming a Second Growth Engine | ||
| UNITEDHEALTH | 345,00 | +0,88 % | UnitedHealth-Aktie: Ende der Abwärtsbewegung? | Die UnitedHealth-Aktie hat ihre jüngste Schwächephase bis unter 400 US$ ausgedehnt, drehte jedoch noch deutlich vor der wichtigen Unterstützung bei 376,22 US$ wieder nach oben. Mit aktuell 403,43 US$... ► Artikel lesen | |
| DRAEGERWERK | 110,60 | +0,18 % | Draegerwerk AG & Co. KGaA: Höhere Margenzuversicht treibt Kursziel auf EUR 130,00; KAUFEN. | Die jüngste Geschäftsentwicklung von Dräger bestärkt uns in unserer Einschätzung, dass sich die Margen strukturell verbessern dürften. Unterstützt wird dies durch höhere Bruttomargen, ein diszipliniertes... ► Artikel lesen | |
| GERRESHEIMER | 29,840 | +1,51 % | PRESSESPIEGEL/Unternehmen: VOLKSWAGEN, BERTELSMANN, GERRESHEIMER, GLENCORE/RADIANT, AIRBUS | DJ PRESSESPIEGEL/Unternehmen
Die wirtschaftsrelevanten Themen aus den Medien, zusammengestellt von Dow Jones Newswires.
VOLKSWAGEN - Im Machtkampf um das nächste Sanierungspaket bei Volkswagen... ► Artikel lesen | |
| THERMO FISHER | 523,00 | -1,02 % | CLSA: Global Pharma Supply Chain Enters Decade-long Restructuring; Prefers Platform Leaders Including Thermo Fisher Scientific Inc, WUXI APPTEC | ||
| TELADOC HEALTH | 5,442 | +0,70 % | Here's Why Teladoc's Integrated Care Business Deserves More Attention | ||
| ESSILORLUXOTTICA | 149,00 | -1,62 % | 160-Milliarden-Dollar-Markt: Warum der nächste Schritt bei Rise Nano Optics nicht mehr im Labor, sondern beim Kunden entscheidet | ||
| HIMS & HERS HEALTH | 23,800 | -0,34 % | Reasons to Retain Hims & Hers Stock in Your Portfolio for Now | ||
| FAMICORD | 2,890 | -1,70 % | Original-Research: FamiCord AG (von Montega AG): Kaufen | Original-Research: FamiCord AG - von Montega AG
31.08.2026 / 14:30 CET/CEST
Veröffentlichung einer Research, übermittelt durch EQS News - ein Service der EQS Group.
Für den Inhalt der Mitteilung... ► Artikel lesen | |
| M1 KLINIKEN | 20,050 | -0,20 % | M1 Kliniken: Warum ich das 26-Euro-Ziel ernst nehme | ||
| BOSTON SCIENTIFIC | 41,205 | +0,11 % | Boston Scientific restoring shipping after cyberattack | ||
| DEXCOM | 74,80 | -1,32 % | Biotech Stocks At 52-Week Highs - Eton Pharmaceuticals +44%, DexCom, Oruka Therapeutics, Concentra Group Holdings Parent, AtaiBeckley | INDIANAPOLIS (dpa-AFX) - The following biotech stocks reached 52-week highs on August 14, 2026, following positive quarterly reports or an announced upcoming acquisition. Eton Pharmaceuticals... ► Artikel lesen | |
| ALIGN TECHNOLOGY | 137,50 | +0,66 % | Align Technology Wins China Patent Case Against Angelalign | WASHINGTON (dpa-AFX) - Align Technology, Inc. (ALGN), said the Jinan Intermediate People's Court in China ruled in its favor in a patent infringement case against Angelalign Technology's Chinese... ► Artikel lesen |
Das Unternehmen SENZIME AB kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell -4,66 % bei einem Aktienkurs von 0,266 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SENZIME AB finden Sie auf Wallstreet Online.